RBC and HTS (Hopper Technology Solutions) Come Together to Elevate the Travel Booking Experience for Canadians
RBC taps HTS to power Avion Rewards Travel, bringing innovative travel offerings to the Canadian market; new travel booking portal to launch later this year for... Read more.
gateretail and JK Tech Partner to Advance AI-Powered Inflight Retail Intelligence
LONDON, March 30, 2026 /PRNewswire/ — gateretail and JK Tech have announced the next phase of their strategic partnership, expanding their collaboration to... Read more.
gateretail and JK Tech Partner to Advance AI-Powered Inflight Retail Intelligence
LONDON, March 30, 2026 /PRNewswire/ — gateretail and JK Tech have announced the next phase of their strategic partnership, expanding their collaboration to... Read more.
RBC and HTS (Hopper Technology Solutions) Come Together to Elevate the Travel Booking Experience for Canadians
RBC taps HTS to power Avion Rewards Travel, bringing innovative travel offerings to the Canadian market; new travel booking portal to launch later this year for... Read more.
National digital series spotlights evidence-based strategies to achieve type 2 diabetes remission through lifestyle interventions
The American College of Lifestyle Medicine and Content With Purpose launch Project Remission: A Lifestyle Medicine Approach to Type 2 Diabetes, a video series featuring... Read more.
RBC and HTS (Hopper Technology Solutions) Come Together to Elevate the Travel Booking Experience for Canadians
RBC taps HTS to power Avion Rewards Travel, bringing innovative travel offerings to the Canadian market; new travel booking portal to launch later this year for... Read more.
National digital series spotlights evidence-based strategies to achieve type 2 diabetes remission through lifestyle interventions
The American College of Lifestyle Medicine and Content With Purpose launch Project Remission: A Lifestyle Medicine Approach to Type 2 Diabetes, a video series featuring... Read more.
Leidos completes $2.4 billion acquisition of ENTRUST
RESTON, Va., March 30, 2026 /PRNewswire/ — Leidos (NYSE:LDOS) has completed its previously announced approximately $2.4 billion acquisition of ENTRUST Solutions... Read more.
National digital series spotlights evidence-based strategies to achieve type 2 diabetes remission through lifestyle interventions
The American College of Lifestyle Medicine and Content With Purpose launch Project Remission: A Lifestyle Medicine Approach to Type 2 Diabetes, a video series featuring... Read more.
IDEAYA Biosciences Announces First-Patient-In for Phase 1 Combination Study of IDE849, DLL3 TOP1 ADC, and IDE161, PARG Inhibitor, in DLL3 Upregulated Solid Tumor Indications, including SCLC, NETs, NECs, and Melanoma
FPI achieved for first-in-class combination of IDE849 (DLL3 TOP1 ADC) and IDE161 (PARG inhibitor). IDE161 (PARG) induced accumulation of TOP1 lesions enhances the... Read more.